Stocks and Investing Stocks and Investing
Fri, July 29, 2011
[ Fri, Jul 29th 2011 ] - Market Wire
Entergy Declares Dividend
[ Fri, Jul 29th 2011 ] - Market Wire
Sallie Mae Announces Dividends
[ Fri, Jul 29th 2011 ] - Market Wire
30 P.M. Eastern

CRYOLIFE INC (NYSE:CRY), Down By 5.48% ($0.31) From $5.660 After BUYINS.NET Report Predicted Weakness After Earnings


Published on 2011-07-29 05:25:34 - WOPRAI
  Print publication without navigation


July 29, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, July 27th 2011 stating that CRYOLIFE INC (NYSE:CRY) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=cry&id=180836

At the time this story was written, CRYOLIFE INC (NYSE:CRY) is Down By 5.48% ($0.31) From $5.660 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

CRYOLIFE INC (NYSE:CRY) - CryoLife, Inc. engages in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries in the United States and Canada. Its CryoValve SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. The companys CryoPatch SG pulmonary cardiac patch has FDA 510(k) clearance for the repair or reconstruction of the right ventricular outflow tract, a surgery commonly performed in children with congenital heart defects, such as tetralogy of Fallot, truncus arteriosus, and pulmonary atresia. CryoPatch SG is distributed in three anatomic configurations: pulmonary hemi-artery, pulmonary trunk, and pulmonary branch. CryoLifes BioGlue Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels. BioGlue is also CE Marked in the European community and approved in Canada and Australia for use in soft tissue repair. The companys BioFoam Surgical Matrix is CE Marked in the European community for use as an adjunct in the sealing of abdominal parenchymal tissues when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. BIOGLUE Aesthetic Medical Adhesive is CE marked in the European Community for periosteal fixation following endoscopic browplasty in reconstructive plastic surgery. CryoLife also distributes HemoStase, a hemostatic agent for use in cardiac and vascular surgery, as well as in various international markets for cardiac, vascular, and general surgery. The company distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. CryoLife was founded in 1984 and is headquartered in Kennesaw, Georgia.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. CRYOLIFE INC (NYSE:CRY) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources